Clin2
NCT07444073Possibly a fitNot yet recruiting

Weight loss and biological aging in a real-world program

AgingObesity & Overweight

Part of Hormones & metabolism clinical trials.

This study looks at how a medical weight-loss program affects your body's aging process. If you are enrolled in the NOVI OP+ program, you may help us understand whether losing weight can slow biological aging.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
440 people
Ages
40 years to 89 years
Study type
Observational

Who can take part

  • You are between 40 and 89 years old.
  • You have obesity (BMI of 30 or higher) or are overweight (BMI 27-30) with a related health problem like diabetes or high blood pressure.
  • You are not pregnant or breastfeeding.
  • You have not used certain medications (like Ozempic, insulin, or sulfonylureas) in the last 3 months.
  • You do not have active cancer on chemotherapy, severe psychiatric illness, or serious memory problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07820774Not yet recruiting
Weight management and health program for older adults

This study tests a program that combines exercise and nutrition to help older adults manage their weight and improve their health. It may help you if you are 60 or older and overweight or obese.

Maringá
NCT06511297Recruiting
How aging and weight affect health: a deep-dive study

This study looks at how aging and body weight affect health and metabolism. Researchers will collect detailed measurements (like scans and blood tests) to understand why some people age better than others. You may join if you are in one of five age/weight groups.

Vienna, State of Vienna
NCT07092618Recruiting· Phase 2/Phase 3
Trial for keeping weight off after stopping GLP-1 meds

This study tests if other medicines (naltrexone, metformin, or rapamycin) can help people keep off weight they lost while taking GLP-1 drugs like Wegovy or Ozempic, after they stop taking them. It is for AgelessRx patients aged 40 to 85 who have lost at least 15 pounds on GLP-1s.

Chicago, Illinois
NCT07535892Not yet recruiting
Keeping weight off after stopping weight-loss medications

This study tests a 6-month behavioral program to help people keep off the weight they lost using GLP-1 or other weight-loss medications after they stop taking those medications. The program includes a 10-week foundational course, virtual sessions, and support to help you maintain your weight loss.

Birmingham, Alabama
NCT07739095Not yet recruiting
Weight loss and hunger study for adults with obesity

This study looks at how weight loss affects hunger in adults with obesity. It involves a walking program and may help you understand your appetite during weight loss.

Ottawa, Ontario
NCT07446907Not yet recruiting
Weight loss program for adults transitioning to older age

This study tests a personalized weight loss program for adults aged 50-75 with a BMI of 30-50. It aims to help you lose weight and improve your health as you get older.

Birmingham, Alabama

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.